News | May 16, 2025
Piramal Pharma reports Q4 FY25 consolidated net profit of Rs. 153.50 Cr
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
The company has posted net profit of Rs. 84.29 crores for the Financial Year ended March 31, 2025
This marks yet another milestone in our series of successful audits over the past year
The company has posted net profit of Rs. 55.36 crores for the Financial Year ended March 31, 2025
The change of name has been carried on pursuant to the Scheme of Amalgamation
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Topiramate is indicated as a treatment of epilepsy and migraine
The company has posted net profit of Rs. 582.01 crores for the Financial Year ended March 31, 2025
The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
